Mangoceuticals (MGRX) Net Cash Flow Growth (1y) (2024 - 2026)
Mangoceuticals (MGRX) Net Cash Flow Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.76 Bn | 24.45 Bn | 662.02 Mn | -43.71% |
| 2 | BrightSpring Health Services | 14.73 Bn | 13.83 Bn | 482.22 Mn | 9,394.16% |
| 3 | Healthequity | 8.35 Bn | 8.09 Bn | 256.31 Mn | -564.99% |
| 4 | Hinge Health | 5.93 Bn | 5.61 Bn | 154.23 Mn | -76.26% |
| 5 | 10x Genomics | 5.90 Bn | 5.36 Bn | 106.18 Mn | -50.15% |
| 6 | MiniMed | 4.48 Bn | 4.18 Bn | 480.00 Mn | 28,500.00% |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | -131.26% |
| 8 | Doximity | 3.95 Bn | 3.20 Bn | 125.97 Mn | 248.05% |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | -175.74% |
| 10 | Mangoceuticals | 9.23 Mn | 9.04 Mn | 29,001.00 | -12,932.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,932.40% |
| Dec 31, 2025 | 14,311.36% |
| Sep 30, 2025 | 191.46% |
| Jun 30, 2025 | -94.08% |
| Mar 31, 2025 | 101.41% |
| Dec 31, 2024 | 98.58% |
| Sep 30, 2024 | 75.69% |
| Jun 30, 2024 | 144.51% |
| Mar 31, 2024 | -122.70% |